Skip to content

Interest Paid at other companies

ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$7.82M-12.0%
Vera Therapeutics logo
Vera TherapeuticsVERA
$1.63M+3.2%
TG Therapeutics logo
TG TherapeuticsTGTX
$2.39M-61.2%
Arrowhead Research logo
Arrowhead ResearchARWR
$4.75K
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$20.32M-12.7%
Roivant Sciences logo
Roivant SciencesROIV
$0-100%

Other financials

Income statement

See full
Revenue$141.0K+95.8%
Operating income-$116.2M-23.8%
Net income-$104.9M-20.7%
EPS (diluted)-$1.15-5.5%

Balance sheet

See full
Cash & equivalents$176.3M+51.7%
Total debt$36.8M+59.4%
Total equity$636.0M+5.2%
Total assets$789.0M+19.4%

Cash flow

See full
Operating cash flow-$119.7M-29.1%
CapEx$23.0K-73.3%
Free cash flow-$119.7M-29.0%

Valuation

See full
Market cap$1.91B+82.0%
Enterprise value$1.77B+85.0%
P/S26.9×-3,445×

Profitability

See full
Gross margin36.3%
Operating margin-543.9%-271pp
Net margin-508.5%-254pp
FCF margin-428.4%-214pp

Returns & leverage

See full
Return on equity-58.1%+7.9pp
Debt / equity0.1×0.0×
Current ratio15.1×-4.3×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s interest paid?
Viridian Therapeutics, Inc. (VRDN) reported interest paid of $1.12M in Q1 2026.
How has Viridian Therapeutics, Inc.'s interest paid changed year-over-year?
Viridian Therapeutics, Inc.'s interest paid increased by 149.8% year-over-year, from $448K to $1.12M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.